Kogenate FS

antihemophilic factor (recombinant) for the treatment of Hemophilia A

Free Trial| EZ Log| Prescribing Information

Contact Us

Search

Learn more about the Kogenate® FS 3000 IU Vial - Now Available

Free Product Trial of Kogenate® FS*

The Kogenate FS Free Product Trial Program provides Kogenate FS,
antihemophilic factor (recombinant) at no cost to:

  • Patients who are newly diagnosed
  • Patients currently receiving other FVIII
Sign up for a Free Product Trial Enrollment for Kogenate® FS or contact your hemophilia account executive

Follow these 3 simple steps to apply for your free product trial of Kogenate FS with BIO-SET:

Please note: Participation in the Kogenate FS with BIO-SET Free Trial Program is not contingent on future treatment purchases.

  1. Download the enrollment form and complete the patient information section in preparation for discussion with your HCP.
  2. Share the completed enrollment form with your healthcare provider and discuss if Kogenate FS with BIO-SET is right for you. If you both agree that it is, your healthcare provider will complete the prescriber information section.
  3. Mail or fax the completed enrollment form for Kogenate FS with BIO-SET to:
  4. Kogenate FS with BIO-SET Free Trial Program
    2400 Lake Orange Drive, Suite 200
    Orlando, Florida 32837
    Fax: 1-866-329-3458

Enroll in the Kogenate FS with BIO-SET Free Product Trial program and receive up to 6 free infusions of Kogenate FS with BIO-SET needleless reconstitution system from Bayer HealthCare Pharmaceuticals, Inc.†

For more information, please call 1-866-329-3449.

Or, contact your local hematology account executive to learn more about the real life protection of Kogenate FS.

Discuss with your doctor whether Kogenate® FS, with Bio-Set® is right for you.

 

*Please note that patients previously enrolled in the Kogenate FS Free Trial program and patients currently receiving Kogenate FS therapy are not eligible to participate in the program.

†Up to 6 free doses to a maximum of 5,000 IU for new patients and 20,000 IU for previously treated patients.

INDICATIONS & USAGE

Kogenate® FS, antihemophilic factor (recombinant), is a recombinant factor VIII treatment indicated for the control and prevention of bleeding episodes and peri-operative management in adults and children (0-16 years) with hemophilia A. Kogenate® FS is also indicated for routine prophylaxis to reduce the frequency of bleeding episodes and the risk of joint damage in children with hemophilia A with no preexisting joint damage.

IMPORTANT SAFETY INFORMATION

The most serious adverse reactions are systemic hypersensitivity reactions and the development of hightiter inhibitors necessitating alternative treatments to AHF. The most common adverse reactions observed in clinical trials were inhibitor formation in previously untreated or minimally treated patients, skin-associated hypersensitivity reactions, infusion site reactions, and central venous access device (CVAD) line-associated infections.

Kogenate® FS is contraindicated in patients who have manifested life-threatening immediate hypersensitivity reactions, including anaphylaxis, to the product or its components, including mouse or hamster proteins.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

For important risk and use information, please see the full prescribing information.

Prescribing Information | Privacy Policy | Terms of Use | Sitemap

© 2010 Bayer HealthCare Pharmaceuticals, Inc. All rights reserved.
BAYER, the Bayer Cross, and Kogenate FS are registered trademarks of Bayer HealthCare Pharmaceuticals.
BIO-SET is a trademark of Biodome SAS.

Kogenate FS Antihemophilic Factor (Recombinant) with BIO-SET Needleless Reconstitution System

Bayer HealthCare Pharmaceuticals